¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24
±³À°ÀÏÀÚ : 2024-05-24
±³À°Àå¼Ò : SKY31 ÄÁº¥¼Ç, ¿ÀµðÅ丮¿ò

±³À°ÁÖÁ¦ : 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷¿ìº´¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 14:10~14:50 WFH 2024 highlight 1: Recent progress in the treatment strategy of hemophilia ÇÑÁ¤¿ì(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 14:50~15:30 WFH 2024 highlight 2:  Hemostasis laboratory in the era of non-replacement therapy ÃÖ¿µ¹è(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 15:30~16:10 Exploring personalized tailored hemophilia treatment ¹ÚÁ¤¾Æ(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 16:30~17:00 Coil Embolization of Unruptured Dissecting Aneurysm in Vertebral Artery of Hemophilia Patient ¹ÚÁö°æ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 17:00~17:30 Pediatric VWD(Von Willebrand disease) patients with recombinant VWF(Von Willebrand disease) concentrates ¹Ú¿µ½Ç(°æÈñÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24
´ÙÀ½±Û 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20341 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ Á¦31Â÷ Ãá°èÇмú´ëȸ : 2024-05-17 0 180 2024-04-03
20340 ¼­¿ï Çѱ¹½ÇÇèÇ÷¾×ÇÐȸ 2024 KSEH Spring Meeting – Revolutionizing technologies to overcome hurdles of cancer research & therapy : 2024-05-17 0 90 2024-04-03
20339 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-GERDÀÇ ÃÖ½ÅÄ¡·á-°¡À̵å¶óÀÎÀ» Áß½ÉÀ¸·Î : 2024-05-16 0 101 2024-04-03
20338 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-05-16 0 119 2024-04-03
20337 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 134 2024-04-03
20336 ¼­¿ï Çѱ¹ÀÓ»ó°íÇ÷¾ÐÇÐȸ 2024³â Ãá°èÇмú¼¼¹Ì : 2024-05-12 0 180 2024-04-03
20335 ¼­¿ï ´ëÇѼö¸é¿¬±¸ÇÐȸ °³¿øÀÇ ¡¤ ºÀÁ÷ÀÇ ¿¬¼ö±³À° : 2024-05-12 0 174 2024-04-03
20334 ¼­¿ï 2024³â ¼­Ãʱ¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-12 0 110 2024-04-03
20333 Ãæ³² Á¦10ȸ ¼øõÇâ´ëÇб³ÀÇ°ú´ëÇРõ¾Èº´¿ø ¼ÒÈ­±â³»°úÇб³½Ç ¼ÒÈ­±âº´ ½ÉÆ÷Áö¿ò : 2024-05-11 0 146 2024-04-03
20332 ¼­¿ï ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ : The 17th SMC Vascular Symposium, 2024 : 2024-05-11 0 104 2024-04-03
20331 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-05-10 0 91 2024-04-03
20330 ¼­¿ï 2024 °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Áý´ãȸ : 2024-05-09 0 80 2024-04-03
20329 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-½Å°æÅ뼺 ÀÌÅëÀÇ Æ¯Â¡°ú ¾à¹°Ã³¹æ ¿ä·É, ¾à¹° ÁÖÀÇ»çÇ× : 2024-05-09 0 107 2024-04-03
20328 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-05-09 0 143 2024-04-03
20327 ºÎ»ê 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-05-04 0 115 2024-04-03
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷